Clinical and arthrosonographic examination of the effect of mechanical stress on entheses before and after fitness training over 12 weeks

Organizational Data

DRKS-ID:
DRKS00033607
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2024-02-07
Last update in DRKS:
2024-04-17
Registration type:
Prospective

Acronym/abbreviation of the study

BEAT3-Fitness

URL of the study

No Entry

Brief summary in lay language

The aim of this study is to investigate whether mechanical stress (fitness session with a personal trainer) causes inflammation of the tendon insertions and whether this inflammatory reaction can be reduced or disappear completely after 12 weeks of independent training with a Theraband. It is known that mechanical stress can serve as a trigger for psoriatic arthritis, but it is unclear whether regular physical exercise reduces this trigger function. With this study, we would like to better understand the development of inflammation of the tendon insertions and counteract it. Ultrasound is an important tool for detecting inflammation in the tendon insertions. As part of the 18-226-3B study, you will be examined with ultrasound before and after the fitness unit after 12 weeks. This is followed by a clinical joint examination and hand strength measurement, which is study-specific in this setting.

Brief summary in scientific language

Psoriasis is a chronic inflammatory disease with a worldwide prevalence of 0.5-11%. Psoriatic arthritis (PsA) is the most common accompanying symptom of psoriasis and affects around 30% of patients with skin symptoms. The special feature of PsA is the inflammation of the tendon insertions, which is also the focus of the disease. It is now known that patients with only skin symptoms can also have arthrosonographic signs of enthesitis. The prevalence of enthesitis in patients with PsA can be estimated at 35%, which underlines the importance of ultrasound diagnostics and raises the question of the causality of enthesitis, which has not yet been clarified. One hypothesis for the development of enthesitis is mechanical stress, whereby a consecutive tissue reaction can lead to such a pathological reaction. However, it has not yet been investigated whether regular targeted physical exercise can reduce or even prevent mechanical stress-induced enthesitis. The aim of this study is to assess the acute effect of mechanical stress on the entheses in healthy volunteers and in patients with psoriasis and psoriatic arthritis

Health condition or problem studied

ICD10:
L40.5 - Arthropathic psoriasis
ICD10:
L40 - Psoriasis
Healthy volunteers:
Yes

Interventions, Observational Groups

Arm 1:
Intervention group: Patients with psoriasis (N= approx. 25) with fitness exercises with Theraband Patients with PsA (N= approx. 25) with fitness exercises with Theraband Healthy subjects (N= approx. 25) with fitness exercises with Theraband
Arm 2:
Control group without any intervention: Patients with psoriasis (N= approx. 25) Patients with PsA (N= approx. 25) Healthy subjects (N= approx. 25)

Endpoints

Primary outcome:
Quantitative (LEI, SPARCC, MASES scores) and qualitative, arthrosonographic assessment of possible enthesitis in the forearms, patellar tendon insertions and Achilles tendons before and after a strenuous training session in the gym (examinations as part of study 18-226-3B) and after a 12-week training session with Theraband before and after another strenuous training session in the gym (measuring point 1 and measuring point 2) Quantitative and qualitative assessment of maximum strength after repetition on the three machines in the gym selected for activation of the triceps brachii, quadriceps femoris and Achilles tendon after a 12-week training session with Theraband (measurement point 1 after 12 weeks).
Secondary outcome:
Quantitative and qualitative assessment of the effects of exercise therapy measures with a fitness band (Theraband) on disease-relevant aspects (including functional ability (HAQ), movement competence (PAHCO), physical activity (BSA, IPAQ), quality of life (SF-36), sleep quality (PSQI), hand strength, fear of movement (TSK)) Quantitative and qualitative recording of clinical parameters such as pain (VAS Pain), inflammation parameters (CRP, BSG) and disease activity (DAS 28, Joint Count 66/68, PASI) after the 12-week training session with a fitness band (Theraband)

Study Design

Purpose:
Other
Allocation:
Randomized controlled study
Control:
  • Control group receives no treatment
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
Randomization 1:1 with an Excel Sheet
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Uniklinik Erlangen Erlangen

Recruitment period and number of participants

Planned study start date:
2024-03-01
Actual study start date:
2024-03-01
Planned study completion date:
2025-12-31
Actual Study Completion Date:
No Entry
Target Sample Size:
150
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Willingness and ability to participate in the study; sufficient knowledge of German to understand the informed consent form or, if not possible, subject information and support in the native language or, if necessary, in English. High probability that patients will be able to participate in the full scope of the study. A signed informed consent form is required for all subjects to participate in this study (the information and education form is enclosed with the application). For the psoriasis and psoriatic arthritis group, a medical diagnosis of psoriasis or psoriatic arthritis is required.

Exclusion Criteria

Other rheumatic diseases such as rheumatoid arthritis. Pregnancy For psoriasis and psoriatic arthritis patients: no change of systemic immunosuppressive therapy in the last 3 months and during the study period

Addresses

Primary Sponsor

Address:
Uniklinik Erlangen
Dr. Harriet Morf
Ulmenweg 18
91054 Erlangen
Germany
Telephone:
09131/8539131
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Uniklinik Erlangen
Dr. Harriet Morf
Ulmenweg 18
91054 Erlangen
Germany
Telephone:
09131/8539131
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Uniklinik Erlangen
Dr. Harriet Morf
Ulmenweg 18
91054 Erlangen
Germany
Telephone:
09131/8539131
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Uniklinik Erlangen
Dr. Harriet Morf
Ulmenweg 18
91054 Erlangen
Germany
Telephone:
09131/8539131
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Uniklinik Erlangen
Ulmenweg 18
91054 Erlangen
Germany
Telephone:
No Entry
Fax:
09131/8539131
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Friedrich-Alexander-Universität Erlangen-Nürnberg
Krankenhausstr. 12
91054 Erlangen
Germany
Telephone:
+40-9131-8522270
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.ethikkommission.fau.de

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2023-07-17
Ethics committee number:
23-272-B
Vote of the Ethics Committee:
Approved
Date of the vote:
2023-09-12

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
The results will be published. The patient data will be summarized and anonymized. The study protocol will be uploaded to the registry and can be viewed at any time. If you have any questions about the study, you can contact us directly by e-mail.

Study protocol and other study documents

Study protocols:
Aktuelles Studienprotokoll
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry